ABT-239
CAS No. 460746-46-7
ABT-239 ( ABT239;ABT 239 )
Catalog No. M14550 CAS No. 460746-46-7
A potent and selective Histamine H3 receptor antagonist with Ki of 0.1-5.8 nM (human, rat H3).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 87 | Get Quote |
|
10MG | 155 | Get Quote |
|
25MG | 335 | Get Quote |
|
50MG | 500 | Get Quote |
|
100MG | 705 | Get Quote |
|
500MG | 1485 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameABT-239
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent and selective Histamine H3 receptor antagonist with Ki of 0.1-5.8 nM (human, rat H3).
-
DescriptionA potent and selective Histamine H3 receptor antagonist with Ki of 0.1-5.8 nM (human, rat H3); exhibits 1000-fold selectivity versus H1, H2 and H4; excellent pharmacokinetic and metabolic properties across species and good oral bioavailability.Pain Discontinued
-
SynonymsABT239;ABT 239
-
PathwayGPCR/G Protein
-
TargetHistamine Receptor
-
RecptorHistamine Receptor
-
Research AreaNeurological Disease
-
IndicationPain
Chemical Information
-
CAS Number460746-46-7
-
Formula Weight330.42
-
Molecular FormulaC22H22N2O
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 3.3 mg/mL
-
SMILESN#CC1=CC=C(C2=CC=C(OC(CCN3[C@H](C)CCC3)=C4)C4=C2)C=C1
-
Chemical NameBenzonitrile, 4-[2-[2-[(2R)-2-methyl-1-pyrrolidinyl]ethyl]-5-benzofuranyl]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Cowart M, et al. J Med Chem. 2005 Jan 13;48(1):38-55.
2. Esbenshade TA, et al. J Pharmacol Exp Ther. 2005 Apr;313(1):165-75.
3. Bhowmik M, et al. Brain Res. 2014 Sep 18;1581:129-40.
2. Esbenshade TA, et al. J Pharmacol Exp Ther. 2005 Apr;313(1):165-75.
3. Bhowmik M, et al. Brain Res. 2014 Sep 18;1581:129-40.
molnova catalog
related products
-
JNJ 39220675
JNJ 39220675 is potent and selective, brain penetrant H3 antagonist with Ki of 1.4 nM, pA2 of 9.42 for hH3.
-
Sodium butanoate
Sodium Butyrate(Butanoic acid sodium salt) has been reported to cause hyperacetylation of histones due to its role as a histone deacetylase (HDAC) inhibitor (IC50 values are 0.3, 0.4, 0.3, mM for HDAC1, 2 and 7 respectively).
-
JNJ-18038683
JNJ-18038683 is a potent, selective 5-HT7 receptor antagonist with pKi of 8.19 and 8.20 for rat and human 5-HT7 in cell-based assays; decreases 5-HT (100 nM)-stimulated adenylyl cyclase in rat and human 5-HT7/HEK293 cells with pKb of 8.01 and 7.99, respectively.